Cancer Awareness Rises in Kerala, But Screening Still Lags Behind

IMT News Desk
IMT News Desk
· 2 min read
White ribbon symbol of peace International day of non violence.

A new statewide survey reveals high awareness of cancer risks among Kerala residents but shows that preventive action remains low.

A survey by the Association of Medical and Paediatric Oncologists of Kerala (AMPOK) has found that 90% of people surveyed in the state were aware of common cancer symptoms, and 80% felt confident in spotting early warning signs. The survey, which included 2,443 participants aged 18 and above, also showed that 84% were concerned about their personal risk of developing cancer.

According to The Economic Times, the findings point to a population that largely understands key risk factors. Nearly 90% of respondents acknowledged the link between smoking and cancer, while 73% saw alcohol consumption as a contributor. Unhealthy lifestyle habits were identified as a cause by 57%, with another 36% partially agreeing. A strong majority believed that tobacco and alcohol use shown by celebrities or athletes could influence younger audiences to adopt these behaviours.

Despite this awareness, only 20% had ever undergone any form of cancer screening. The AMPOK team noted that while knowledge of cancer risk is high, preventive steps such as regular screening, vaccinations, and genetic testing are not being widely followed. Some misconceptions continue to persist. Around 18% believed mobile phone usage causes cancer, and 25% thought safe pesticide use could lead to cancer, indicating that misinformation still needs to be addressed.

Dr. Aju Mathew, chairman of AMPOK, stated that the survey reflects both progress and ongoing challenges. He highlighted that bridging the gap between awareness and action is essential. Improving access to screening and educating the public on preventive care beyond lifestyle changes will be key in reducing future cancer burdens.

The survey offers a window into how public health messaging is being received and where more targeted strategies are needed to turn knowledge into consistent preventive behaviour.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk